Tularik
Executive Summary
Former SmithKline Beecham Director-New Product Development James Huang appointed VP-business development and commercial operations, a newly created position. At SmithKline, Huang led the launch of the diabetes drug Avandia. Huang will be taking over and expanding on the business development responsibilities of Yasunori Kaneko, who is currently heading Tularik's partnership with Japan Tobacco, which involves diabetes agent development